Business Context and Reporting Period
Oragenics, Inc. filed this Form 8-K on January 24, 2011, to report the entry into a material definitive agreement. The company is incorporated in Florida and is headquartered in Tampa, FL.
Key Financial Metrics
This filing details a specific financing transaction rather than comprehensive financial statements. Key metrics related to the credit facility include:
- Total Credit Facility Limit: Increased from $2,000,000 to $2,500,000.
- Total Borrowed Amount: $2,500,000 (fully drawn).
- Interest Rate: LIBOR plus 6.0%.
- Maturity Date: August 1, 2011.
- Lender: Koski Family Limited Partnership (KFLP), an accredited investor and the Company's largest shareholder.
Material Changes
On January 24, 2011, the Company entered into a First Amendment to its existing unsecured revolving credit agreement originally dated July 30, 2010. The material changes include:
- Expansion of the borrowing capacity by $500,000.
- Immediate drawdown of the additional $500,000, bringing total outstanding debt under this facility to $2,500,000.
- The transaction was approved by the Company's disinterested directors.
Outlook, Risks, and Commentary
The filing does not provide forward-looking guidance, management commentary on future operations, or a discussion of general risks beyond the terms of the debt agreement. The debt is unsecured and matures in less than one year from the filing date.
Investor Verification Checklist
- Verify the current LIBOR rate to calculate the exact interest expense on the $2.5 million debt.
- Confirm the Company's cash position to assess liquidity relative to the $2.5 million debt obligation due August 1, 2011.
- Review the relationship with KFLP to understand potential conflicts of interest given their status as the largest shareholder and lender.
- Check subsequent filings for any further amendments or defaults on this credit facility.